首页> 外文期刊>International journal of gastrointestinal cancer >Biological similarities and differences between pancreatic intraepithelial neoplasias and intraductal papillary mucinous neoplasms.
【24h】

Biological similarities and differences between pancreatic intraepithelial neoplasias and intraductal papillary mucinous neoplasms.

机译:胰腺上皮内瘤变与导管内乳头状黏液性肿瘤之间的生物学相似性和差异。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Ever since the classification of pancreatic intraepithelial neoplasia (PanIN) was published, studies on the precursor lesions of pancreatic cancer have been advancing along a new directions, using standardized terminology. There are few studies that have examined the biological differences between PanIN and intraductal papillary mucinous neoplasm (IPMN) in detail. Aims: PanIN and IPMN, which are similar in morphology, were compared using various indicators, with the aim of identifying the similarities and differences between the two. Methodology: A total of 46 PanINs and 37 ducts with IPMN were identified in 19 patients with invasive ductal carcinoma and 18 patients with IPMN. These PanINs and IPMNs were examined immunohistologically with respect to the expression patterns of HER2eu, DPC4/Smad4, Akt/PKB, p53, cyclin A, Ki67, MUC1, and MUC2. Results: Significant differences in the expression of MUC1 and MUC2 were observed between IPMNadenoma and PanIN-2 and between CIS and PanIN-3 (MUC1: p= 0.001 and p = 0.005, respectively; MUC2: p = 0.002 and p < 0.001, respectively). Asignificant difference in the p53 expression level was also observed between CIS and PanIN-3 (p = 0.015). Conclusions: In both IPMN and PanIN, the grade of atypism increased with increasing expression of HER2eu, DPC4/Smad4, and Akt/PKB, along with progression in the process of multistage carcinogenesis. Although the expression levels of these factors reflected the grade of atypism, they did not reflect any differences in the grade of biological malignancy between IPMN and PanIN. On the other hand, MUC1 and MUC2 may serve as indicators of the direction of differentiation, i.e., either progression to IDAC or IPMN. Positivity for MUC1 was believed to suggest differentiation into IDAC, and positivity for MUC2 appeared to be indicative of differentiation into IPMN. Such indication of the direction of differentiation seemed to appear in PanIN1-2, even before abnormalities of HER2eu, Akt/PKB, DPC4/Smad4, p53, and cyclin A expression began to be detected.
机译:背景:自从胰腺上皮内瘤变(PanIN)的分类发表以来,使用标准化术语对胰腺癌前体病变的研究一直朝着新的方向发展。很少有研究详细检查PanIN和导管内乳头状黏液性肿瘤(IPMN)之间的生物学差异。目的:使用各种指标对形态相似的PanIN和IPMN进行比较,以识别两者之间的异同。方法:在19例浸润性导管癌患者和18例IPMN患者中共鉴定出46个PanIN和37个IPMN导管。相对于HER2 / neu,DPC4 / Smad4,Akt / PKB,p53,细胞周期蛋白A,Ki67,MUC1和MUC2的表达模式,对这些PanIN和IPMN进行了免疫组织学检查。结果:在IPMNadenoma和PanIN-2之间以及在CIS和PanIN-3之间观察到MUC1和MUC2表达的显着差异(MUC1:分别为p = 0.001和p = 0.005; MUC2:分别为p = 0.002和p​​ <0.001 )。在CIS和PanIN-3之间也观察到p53表达水平的显着差异(p = 0.015)。结论:在IPMN和PanIN中,随着HER2 / neu,DPC4 / Smad4和Akt / PKB的表达增加,以及在多阶段癌变过程中的进展,非典型性程度也增加。尽管这些因子的表达水平反映了非典型性的程度,但它们并未反映IPMN和PanIN之间的生物恶性程度的任何差异。另一方面,MUC1和MUC2可以用作分化方向的指标,即向IDAC或IPMN的发展。据信MUC1的阳性表明已分化为IDAC,MUC2的阳性似乎表明已分化为IPMN。甚至在开始检测到HER2 / neu,Akt / PKB,DPC4 / Smad4,p53和cyclin A表达异常之前,这种分化方向的指示似乎出现在PanIN1-2中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号